A trial fibrillation (AF) remains common in the setting of myocardial infarction (MI) despite the increasing use of early reperfusion strategies. [1] [2] [3] [4] [5] When AF occurs after MI, it tends to recur in >20% during follow-up. 1, 6 Although the prognostic significance of AF after MI is well-established, [2] [3] [4] 7, 8 the mechanism for this heightened risk is not fully understood. The relative contribution of atrial ischemia, ventricular dysfunction, hemodynamic changes, and neurohumoral abnormalities to the development of AF after MI has not been evaluated.
blood supply provides a unique model to evaluate the role of atrial ischemia/infarction. In this study, we induced acute MI in an ovine model to understand the mechanism by which MI results in the substrate for AF. In particular, by evaluating the differences in LCX and LAD infarction, we aimed to determine the contribution of atrial ischemia/infarction in creating the AF substrate while controlling for other perpetuators, such as atrial stretch, hemodynamic change, and neurohumoral activation.
Methods
Forty-four Merino Cross Wethers with a weight of 56±8 kg were studied (Figure 1 ). After acclimatization, animals were allocated to either MI (equally with LAD and LCX occlusion) or control (Shamoperated) group. All procedures were conducted in accordance with the guidelines outlined in the Position of the American Heart Association on Research Animal Use. Approval for the performance of the study was provided by the Animal Ethics Committees of the University of Adelaide and SA Pathology, Australia.
Study Protocol
All procedures were performed under general anesthesia. Sodium thiopental (15-20 mg/kg) was used for induction to facilitate endotracheal intubation and isoflurane (2% to 4%) in 100% oxygen was used for maintenance. Invasive blood pressure, heart rate, LA pressure (LAP), end-tidal CO 2 , oxygen saturation, and temperature were continuously monitored throughout the study protocol.
Myocardial Infarction
MI was induced by percutaneoulsy cannulating the left coronary system using a guiding sheath (AL1; Boston, MA) and then inflating a angioplasty balloon (Voyager NC, Abbott Group). The angioplasty balloon was sized and inflated to achieve a total occlusion of either the LAD or LCX vessels. Among 44 animals, 11 developed fatal arrhythmia without completion of the study and were, therefore, excluded. The remaining 33 animals were equally divided into 3 groups: occlusion of proximal-LCX (n=11; to induce left atrial ischemia/infarction in addition to left ventricular infarction); occlusion of proximal LAD (n=11; left ventricular [LV] infarction with no atrial ischemia/infarction); and 11 sham-operated controls animals undergoing the identical protocol without MI. The angioplasty balloon was kept inflated for 45 minutes and acute ischemia was confirmed on surface ECG.
The left ventricular ejection fraction was assessed using echocardiography at baseline and 30 minutes after balloon inflation. The presence of infarction was identified by staining with 2,3,5 triphenyl tetrazolium chloride. [18] [19] [20] 
Electrophysiology Study
Open chest electrophysiological studies were performed. Using a limited pericardiotomy, a custom designed 64-electrode plaque with 5 mm interelectrode distance was applied to the LA. Surface ECG and overlapping bipolar electrograms were continuously monitored and stored for off-line analysis using a computerized recording system (LabSystem Pro, Bard Electrophysiology, Lowell, MA). Electrograms were filtered from 30 to 500 Hz and measured with computer-assisted callipers at a sweep speed of 200 mm/s. Electrophysiological evaluation was performed at 15-minute intervals until the termination of the procedure. The following parameters were determined at each time point:
Atrial Refractoriness
Left atrial effective refractory periods (ERP) was measured by pacing from one prespecified corner of the plaque at twice diastolic threshold at cycle lengths of 400 and 250 ms. A single extrastimulus (S2) was introduced after 8 basic stimuli (S1) starting with a coupling interval of 300 ms and reducing in 10 ms decrements until loss of capture. Atrial ERP was defined as the longest S1-S2 interval not resulting in a propagated response. The ERP was measured 3× at each cycle lengths at each time point, and if the maximum and minimum differed by >10 ms, 2 additional measurements were taken and the total was averaged.
Atrial Conduction
Conduction was assessed during stable S1-pacing at 400 and 250 ms. Activation maps were created using semiautomated custom-made software. 21, 22 Each annotation was manually verified with the local activation time annotated to the peak of the largest amplitude deflection on bipolar electrograms. Local conduction velocity was calculated from the local vectors within each triangle of electrodes as previously described. 21, 22 A mean conduction velocity can then be derived.
Conduction heterogeneity was assessed using phase-mapping techniques during S1-pacing. 23 In brief, the largest activation time difference between every 4 adjacent electrodes was first determined and divided by interelectrode distances. The largest value at each site was then used to create a phase map, with values also displayed as a histogram. Absolute conduction phase delay was calculated by subtracting the 5th from 95th percentile (P5-95). The conduction heterogeneity index was calculated by dividing the absolute phase delay by the median (P50). The conduction heterogeneity index is used to evaluate the heterogeneity in conduction in the atrial tissue.
AF Vulnerability
The inducibility and duration of AF were evaluated using programmed extra stimuli during ERP testing. Induced AF was documented with percentage of inducibility taken as the number of AF episodes over the total number of S1-S2 drive. AF was defined as a rapid irregular atrial rhythm of ≥2 s. Mean duration of AF episodes were derived from the average of all induced episodes in each group. Sustained AF was defined as arrhythmia of >10 minutes duration. If AF was sustained, no further data were collected.
Statistical Analysis
Data analysis were performed using SAS version 9.2 (SAS Institute Inc, Gary, NC). All continuous variables are reported as mean±SD and assessed for normality using the Shapiro-Wilk test. The changes in hemodynamic were assessed using an ANOVA. To compare changes in the outcome measures among the 3 treatments groups, a linear mixed effects model was fitted to the data. In the model, treatment group, time, and the interaction between treatment group and time were fitted as fixed effects, whereas animal was fitted as a random effect. The changes in the electric properties were assessed at 0, 15 minutes, 30 minutes, and 45 minutes after balloon inflation. Kruskal-Wallis test was used to compare AF duration between the groups. Because of high variation or overdispersion of AF incidence data among the groups over 45 minutes, negative binomial regression was used to compare AF incidence between the groups. Statistical significance was established at P<0.05.
Results
A total of 33 animals were studied in the following groups: LCX occlusion (n=11; ventricular and atrial ischemia/infarction); LAD occlusion (n=11; ventricular infarction alone); and control (n=11; sham-operated; Figure 1 ). At the end of the study, 2,3,5 triphenyl tetrazolium chloride staining demonstrated that the LCX, and not the LAD group or the controls, had atrial infarction (LCX 11 versus LAD 0; P<0.05 and LCX 11 versus control; P<0.05). Figure 2 demonstrates the hemodynamic changes seen in each group. There was no significant difference between the groups in mean arterial blood pressure over time. The left ventricular ejection fraction (LVEF) was similar between the groups at baseline (LCX versus LAD versus control: 60±4 versus 61±3 versus 62±5%; P=ns). There was a significant reduction in LVEF in the 2 MI groups 30 minutes after balloon inflation compared with control (LAD 37±2.7% [P=0.0002]; and LCX 36±4% [P=0.0001]); however, there was no significant difference in LVEF between MI groups (P=0.2). In keeping with reduction of LVEF, there was significant increase in LAP in MI groups compared with control (LCX: P<0.001; and LAD: P<0.001; Figure 2A ). Importantly, this increase in LAP demonstrated no difference between the LCX and LAD groups (P=0.2).
Hemodynamic and Heart Rate Changes
There was no difference in heart rate between the groups at baseline (P=0.6; Figure 2B ). However, with MI, animals in both MI groups became more tachycardic compared with control at 30 minutes after balloon inflation (LCX versus control [P=0.02]; LAD versus control [P=0.03]). There was no significant difference in heart rate between LCX and LAD over time (P=0.5).
Atrial Electric Changes Because of MI

Effective Refractory Period
The left atrial ERP shortened in both MI groups compared with control (P=0.004); however, there was no significant differences between the MI groups (P=0.6). The reduction in ERP was observed as early as 15 minutes but became statistically significant 30 minutes after MI ( Figure 3 ). Figure 4 demonstrates representative examples of activation maps in each group. Activation contours drawn at equal time intervals highlight areas of isochronal crowding. This figure demonstrates that although there are some changes observed in the LAD group, the most marked impact on conduction was in the LCX group.
Conduction Velocity
With MI, there was a reduction in atrial conduction velocity ( Figure 5 ). LV infarction alone, as observed in the LAD group, induced a modest but significant change in conduction compared with control (P=0.01). However, with additional atrial ischemia as observed in the LCX group, there was marked and progressive slowing of conduction compared with LAD (P<0.001) or control (P<0.001).
There was also evidence of significant increase in conduction heterogeneity as reflected by the absolute range of conduction phase delay (p5-95, expressing the total range in maximal differences in activation time) and the conduction heterogeneity index (to express the heterogeneity of conduction, overall mean P5-95/P50; Figure 6 ). The absolute range of conduction phase delay was increased in the LCX group compared with LAD (P<0.001) or control (P<0.001; Figure 6A ). The conduction heterogeneity index was markedly increased in the LCX group compared with LAD (P<0.0001) or control (P<0.001; Figure 6B ). There were no differences in these parameters of conduction heterogeneity over time in the LAD and control groups. Figure 7A shows the number of AF events by group. The AF incidence rate ratio (IRR) was significantly higher in LCX compared with LAD (LCX versus LAD, IRR, 6 [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] ; P=0.001) or control group (LCX versus control, IRR, 12 [3.26-44.14]; P<0.001, negative binomial model). In contrast, there was no significant differences in IRR between the LAD and control groups (IRR, 2 [0.47-8.5]; P=0.4). In addition, when AF developed, it persisted for a significantly longer duration in LCX group compared with LAD or control groups (P<0.05; Figure 7B ). Three (27%) in LCX groups developed sustained AF, whereas this was not observed in the other groups.
AF Vulnerability
Discussion
This study provides new information on the relative contribution of atrial ischemia/infarction to the development of the substrate for AF associated with MI. Using the ovine coronary circulation, that has differential blood supply to the atria (supplied by the LCX) but equal supply to the ventricle from the LAD and LCX, it demonstrates that:
1. Atrial ischemia is the important determinant for the development of the AF substrate during MI. This is characterized by slowed and heterogeneous conduction. These abnormalities were independent of LV function or the hemodynamic changes that occur during the acute phase of MI. As a result of these abnormalities, not only AF was more frequently induced, but it also more frequently became sustained. 2. Acute MI, independent of atrial ischemia, results in significant hemodynamic changes and atrial stretch. These factors were associated with the abbreviation of ERP but only modest change in the conduction properties of the atria.
Although the incidence of AF and its prognosis after MI has been extensively studied, [2] [3] [4] 7, 8, 24 data on AF pathophysiology after MI is limited. 9 To our knowledge, no previous study has evaluated the relative influence of factors associated with acute MI that contribute to the AF substrate.
Ventricular Infarction, Atrial Stretch, and the Hemodynamic Changes
Ventricular infarction in both LCX and LAD groups resulted in comparable moderate LV dysfunction with similar changes in heart rate and blood pressure with early and persistent rise in LA pressure. As such, the electromechanical response to ventricular infarction would be of a similar intensity in both groups. This was associated with equivalent significant reduction in ERP in both MI groups. In addition, the acute LA stretch resulted in a modest slowing in conduction velocity (with proximal LAD occlusion). These findings are consistent with previous animal studies showing that electromechanical feedback is produced by activation of stretch activated channels, which can effect both inward and outward ionic currents and lead to shortening action potential duration, increased automaticity, and trigger activity. [25] [26] [27] Shortening of the action potential and ERP has also been demonstrated in the ventricles. [28] [29] [30] However, other studies in human or dogs have provided conflicting results on the effect of acute pressure or volume load on atrial refractoriness, attributed as the means of causing stretch or the degree of stretch. 31, 32 The acute LA stretch with associated neurohumoral changes resulted in abbreviation of atrial ERP and may partially explain the increased inducibility of AF observed with ventricular infarction alone.
Atrial Ischemia or Infarction
LA ischemia/infarction because of occlusion of proximal LCX artery resulted in profound slowing in conduction velocity with increased areas of isochronal crowding and marked increased in heterogeneity in conduction, all established prerequisites for the development of reentry and AF. 9 Sinno et al 9 have previously observed similar findings when targeting isolated atrial branches. Although clinically isolated atrial branch occlusion is rare, the findings of this study, mimicking the clinical scenario, confirm the importance of atrial ischemia in the development of the AF substrate. AF after MI tends to recur in >22% of the cases during late follow-up. 1, 6 Although LV dysfunction is strongly associated with development of AF recurrence after MI, 6 some studies have shown AF recurrence post-MI was independent of LV dysfunction. 1 Furthermore, patients post-MI with atrial structural abnormalities, such as enlarged LA, have increased propensity for AF recurrence. In a canine model of chronic (>7 days) coronary artery occlusion, Nishida et al 33 found that stable reentrant sources at the border of atria infarcted area was associated with significant peri-infarct fibrosis. Atrial fibrosis is likely an important factor in stabilizing reentry and promoting AF. Acute atrial ischemia together with LA stretch synergistically interacts resulting in significant slowing in conduction velocity and marked increase in conduction heterogeneity as observed in LCX group. These electrophysiological changes are consistent with previous observations at the ventricular level. 34, 35 In addition, the significant reduction in atrial ERP observed with acute MI is consistent with observations by Jayachandran et al. 36 However, the reduction in ERP in this study was equivalent and persistent in both LCX and LAD group suggesting that it was more likely because of LA stretch and the associated hemodynamic and neurohumoral changes associated with MI rather than because of atrial ischemia per se.
Mechanisms of Ischemia Related Atrial Changes
The major pathophysiological conditions resulting from acute MI are elevated extracellular potassium, acidosis, and anoxia. These changes lead to reduction in membrane excitability, shortening of action potential duration, and prolongation of recovery of excitability after an action potential. 37, 38 It is difficult to determine the ionic mechanisms of the electric changes and the contribution of each pathophysiological condition to each electric change. However, using an ionic-based theoretical model of cardiac ventricular cells exposed to the above pathological conditions (elevated [K] 0 , acidosis and anoxia), Shaw et al 38 found that the depression of membrane excitability and delayed recovery of excitability caused by elevated [K] 0 with additional excitability depression by acidosis. In addition, the major changes in action potential duration (shortening) can only be explained by anoxia-dependent opening of I K (ATP).
Clinical Implication
Atrial ischemia or infarction with increased LA pressure plays an important role in LA electric changes that promotes AF occurrence during the acute phase of MI. It is likely that such changes may be responsible for the late and significant recurrences of AF after MI. Recent clinical data has suggested the importance of atrial branch compromise in patients with coronary artery disease as an important determinant of developing AF. 14 Given the paroxysmal nature of AF after MI with usage of dual antiplatelet therapy in patients with coronary stenting, oral anticoagulation has been underused in this population.
The drug efficacy in treating AF may be related to the underlying mechanisms. 39 In experimental models, class III antiarrhythmic drugs are more effective in AF associated with structural remodeling than in atria remodeled by sustained atrial tachycardia. Likewise β-blockade and calcium channel blockers inhibit the arrhythmogenic consequences of acute atrial ischemia, whereas Na + channel or K + -channel blockers are ineffective. 40 In addition, other studies have also shown the favorable effect of early coronary reperfusion on AF incidence post-MI which may, in part, be explained by reduced total ischemic burden at both the ventricular and atrial level. 14, 41 Atrial ischemia or infarction is rarely considered as a direct contributor to the development of AF after AMI. This study showed the direct relation between AF and atrial infarction. Moreover, the efficacy of different antiarrhythmic drugs may be related to the underlying substrate with the potential therapeutic implications of AF mechanisms related to acute atrial infarction.
Study Limitations
This study evaluated the changes in the atrial electric changes during the initial 45 minutes of MI. The impact of neurohumoral factors has not been fully evaluated in this study. Finally, this is an ovine model with MI induced by balloon inflation in the coronary arteries; the pathogenesis of MI in humans is the result of plaque rupture and thrombosis, which might imply a different cardiovascular response.
